Funding for this research was provided by:
Institute of Cancer Research (MOP#389137)
Text and Data Mining valid from 2018-12-01
Received: 10 July 2018
Accepted: 9 December 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: SMV is a co-inventor on a U.S. provisional patent application No. 62/588,639: Induction of mismatch repair deficiency in cancer cells and application thereof.accountable for all aspects of the work (SMV).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.